NITA ABRAHAM: Open Payments
NPI 1366934556 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 30 payments from 13 companies in 2025. Trend: 2023 $958 · 2024 $1,126 · 2025 $1,220
Food & beverage: $1,220
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $256 |
| AstraZeneca Pharmaceuticals LP | 6 | $174 |
| BridgeBio Pharma, Inc. | 1 | $135 |
| Alnylam Pharmaceuticals Inc. | 1 | $128 |
| Amgen Inc. | 5 | $111 |
| ABIOMED | 1 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Novo Nordisk Inc | 2 | $58 |
| Abbott Laboratories | 2 | $50 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $49 |
Products named: WATCHMAN FLX, Attruby, AMVUTTRA, FARXIGA, LOKELMA, LEQVIO, Wegovy, LifeVest.
Industry payments across NC — which companies pay providers there.
